Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Liquidity (Details Textual)

v3.21.2
Note 2 - Liquidity (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 10 Months Ended 12 Months Ended
Aug. 12, 2021
Jul. 08, 2021
Mar. 02, 2021
Feb. 23, 2021
Aug. 31, 2020
May 18, 2020
Aug. 12, 2021
Jan. 31, 2020
Dec. 31, 2019
Nov. 30, 2017
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Dec. 31, 2019
Dec. 31, 2020
Aug. 30, 2020
Common Stock, Par or Stated Value Per Share (in dollars per share)                     $ 0.001     $ 0.001   $ 0.001   $ 0.001  
Proceeds from Issuance of Common Stock               $ 812,000 $ 1,900,000         $ 2,133 $ 3,025,040   $ 1,100,000    
Stock Issued During Period, Shares, New Issues (in shares)                 2,100,000                    
Stock Issued During Period, Value, New Issues                     $ 1,800,000   $ 700,000            
Stock Subscriptions and Other Receivables                     2,400,238     2,400,238   $ 2,400,238   $ 2,987,319  
Proceeds from Notes Payable, Total                           0 366,000        
Gain (Loss) on Extinguishment of Debt, Total                     0   0 366,000 $ 0        
Paycheck Protection Program CARES Act [Member]                                      
Proceeds from Notes Payable, Total           $ 366,000                          
Gain (Loss) on Extinguishment of Debt, Total       $ 366,000                              
Series D Preferred Stock [Member]                                      
Stock Issued During Period, Value, New Issues                       $ 250,001              
Stock Subscriptions and Other Receivables                     $ 2,200,000     $ 2,200,000   $ 2,200,000      
Series E Preferred Stock [Member]                                      
Stock Issued During Period, Value, New Issues                       $ 4,980,709              
Subsequent Event [Member] | Series E Preferred Stock [Member]                                      
Conversion of Stock, Shares Converted (in shares) 0                                    
Keystone Capital Partners, LLC [Member] | Series D Preferred Stock [Member]                                      
Stock Issued During Period, Shares, New Issues (in shares)         150,000                     72,500      
Stock Issued During Period, Value, New Issues         $ 15,000,000.0                            
Stock Purchase Agreement, Shares Remaining (in shares)                     77,500     77,500   77,500      
Keystone Capital Partners, LLC [Member] | Series D Preferred Stock [Member] | Maximum [Member]                                      
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)         5,147,000                            
Keystone Capital Partners, LLC [Member] | Subsequent Event [Member] | Series D Preferred Stock [Member]                                      
Stock Issued During Period, Shares, New Issues (in shares)   22,077                                  
Stock Issued During Period, Value, New Issues   $ 2,200,000                                  
John K. Scott, Jr. [Member] | Series E Preferred Stock [Member]                                      
Stock Issued During Period, Shares, New Issues (in shares)     50,000                                
Stock Issued During Period, Value, New Issues     $ 5,000,000.0                                
Preferred Stock, Convertible, Shares Issuable (in shares)     2,173,913                                
Private Placement [Member]                                      
Stock Issued During Period, Value, New Issues                         $ 520,030            
Private Placement [Member] | Mastiff Group LLC [Member]                                      
Sale of Stock, Commitment Amount                     $ 4,975,000     $ 4,975,000   $ 4,975,000   $ 4,975,000 $ 25,000,000.0
Common Stock, Par or Stated Value Per Share (in dollars per share)                                     $ 0.001
Private Placement [Member] | Mastiff Group LLC [Member] | Subsequent Event [Member]                                      
Proceeds from Issuance of Common Stock $ 25,000           $ 25,000                        
Platinum-Montaur Life Sciences LLC Litigation [Member]                                      
Loss Contingency, Damages Sought, Value                   $ 1,900,000                  
CRG Loan Agreement, Ohio Case [Member]                                      
Loss Contingency, Damages Sought, Value                           $ 4,300,000